The Neurogenx 4000PRO is a cutting-edge electromedical treatment tool that is FDA-cleared and patented as the only device of its kind. It generates a sophisticated electronic signal with a wide frequency band to safely treat the pain, tingling, burning and numbness that are the hallmark symptoms of neuropathy and chronic nerve conditions. It is a conservative standalone treatment that does not requiresurgery or narcotics.

Breakthrough Neuropathy Treatment

High Patient Success Rate

Pain Cramping Burning **Results confirmed by nerve conduction studies, nerve fiber density tests and balance plate testing.**Numbness Hyper-Sensitivity Tingling

In more than 4 out of 5 patients, treatment with resolved neuropathy symptoms & restored function!

In more than 4 out of five patients, treatment resolved or rapidly reduced neuropathy symptoms such as:

www.neurogenx.com/princeton

609-356-1450

Diabetes CMT Plantar Fasciitis Phantom Limb

Fibromyalgia CRPS Radiculopathy Neuritis

Restless Leg Syndrome TTS/CTS Inflammatory

ConditionsVascular

Conditions

Viral Infection MS Post-op pain Migraines

Treatment with Neurogenx 4000PRO is effective regardless of the origin of the neuropathy, safely treating neuropathic symptoms resulting from:

Effective Regardless of Neuropathy Cause

Steven Weinshel, MD, JD Medical Director

A physician, attorney and retired Major from the U.S. Air Force Reserves, Dr. Weinshel has nearly 30 years of medical practice experience. Formerly the Chief of Neurological Surgery at David Grant USAF Medical Center, he is a neurological trauma specialist experienced in the treatment of peripheral

nerve conditions. Dr. Weinshel is Board Certified in Neurological Surgery.

Olivia R. Kent, MD, JD, MS Executive Director & Physician Liaison

A physician, attorney and Johns Hopkins University educated biomedical engineer, Dr. Kent is excited to be a part of bringing the Neurogenx Treatment to New Jersey. She looks forward to guiding patients and physicians alike toward a broader knowledge of this cutting-edge technology.

Dedicated to making a positive difference in the lives of others, Dr. Kent is committed to helping neuropathy patients enjoy healthy, pain-free lives with their families and loved ones. A life-long New Jersey resident, Dr. Kent is married and has “three beautiful, amazing, inspiring children.” Outgoing and compassionate, she looks forward to helping your patients find a better quality of life.

The Neurogenx treatment can provide restorative results that go beyond pain management for patients with complex neuropathic issues that are not responding to traditional protocols or for patients who no longer wish to rely on narcotic solutions.In addition, we understand the difficulties faced by patients coping with what is often a life-altering issue, thus our interactions are compassionate and supportive. We would be honored to help make a difference in your patients’ lives.

Proven Restorative Results

Treatment Partners, Committed To Your Patients

Our entire staff is committed to helping you improve the wellbeing of your patients who are struggling with peripheral neuropathy.

We are certified experts in the restorative Neurogenx Electronic Signal Technology. This treatment modality helps resolve nerve pain, numbness, tingling, etc. without the use of pharmaceuticals and provides long-term, measurable results.

Our responsive referral support includes treatment status reports delivered to your office and easy access to our director for peer-to-peer consultations. Your status reports include your patient’s ongoing balance testing results - objective data that tracks and confirms treatment progress.

When you have diagnosed neuropathy, partner with Neurogenx to support your treatment plan and help you deliver positive outcomes.

Your referral to our Center is the highest honor.

Many professional journals have documented the success of the technology.

609-356-1450 134 Franklin Corner Road, Suite 106, Lawrence Township, NJ 08648

www.Neurogenx.com/Princeton

134 Franklin Corner Road, Suite 106Lawrence Township, NJ 08648

Phone: 609-356-1450

Restorative Treatment forPeripheral Neuropathy

& Chronic Nerve Conditions

1

Practical PAIN MANAGEMENT, April 2006

©2006 PPM Communications, Inc. Reprinted with permission.

Electroanalgesic medical treatment

involves the use of computer-mod-

ulated electronic signals to imitate,

exhaust or block the function of somatic

or sympathetic nerve fibers. An elec-

troanalgesic medical device (EAD), utiliz-

ing communications-level technology, is

used to produce and deliver higher-fre-

quency signal energy in a continually

varying sequential and random pattern

via specialty electrodes. These electrodes

of specific size, shape, and anatomical

placement, can be effectively used to ob-

tain pharmaceutical effects.1,2 Elec-

troanalgesic treatment for accomplishing

nerve fiber block procedures typically use

very small targeting electrodes (approx.

¾"-1.5" diameter), while electroanalgesic

physical medicine treatments tend to use

much larger electrodes (4" or more in di-

ameter).This electronically and digitally gener-

ated energy pattern also follows quarter-

tone incremental steps with a pause at

specific harmonic frequencies selected for

their desired effects or mechanisms of ac-

tion. This selection of specific frequencies

effectively increases the initiation of tis-

sue resonance phenomenon in the mi-

crostructure and macromolecular range.

Some well known and well documented

mechanisms of action employed by this

harmonic resonance include the imitation

of hormone/ligand effects, activation of

cellular regeneration, and the facilitation

of enzymatic metabolic processes.3,4,5 The

EAD unit used in the subsequent case re-

ports was the Sanexas Neo GeneSys de-

vice.

Background

The use of electrical signals for various

medical treatments has been mentioned

since ancient times with the earliest man-

made records (2750 BC) discussing the

electrical properties and treatment po-

tential of the Nile catfish, Malopterurus

electricus.6 Subsequent writings of Celsius,

Oribasius, and other compilers describe

medical treatment with electric fish by

Hippocrates (420 BC) but little else until

about 46 AD, at which time the Roman

physician, Scribonus Largus, introduced

the electrical capabilities of the fish into

clinical medicine as a cure for intractable

headache pain, neuralgia, joint inflam-

mation, and gout.

In the 1700s, European physicians doc-

umented the use of controlled electrical

currents from electrostatic generators for

numerous medical problems involving

pain and circulatory dysfunction. During

that period, Benjamin Franklin also doc-

umented pain relief by using electrical

currents for a number of ailments includ-

ing frozen shoulder.

Today, the clinical use of electromed-

ical modalities in both diagnosis and

treatment is well documented with basic

and physical science replete with refer-

ences demonstrating the positive effects

on patients for a myriad of medical con-

ditions.7 Transcutaneous Electrical Nerve

Stimulation (TENS) treatment is a well-

documented, mild form of electroanalge-

sia that has been shown to provide pain

relief by administering small electrical

currents through the skin. It is believed

that the primary physiological mecha-

nism of action achieved via standard

TENS application is due to a direct count-

er-irritation of the central nervous system

(CNS); the mechanism of action is consis-

tent with the Gate Control Theory of Pain

by Melzak and Wall.8,9

Electroanalgesia nerve blocks, both at

the stellate ganglion and the lumbar sym-

ELECTROANALGESIC

NERVE BLOCK

Theory and case reports on an

advanced generation electroanalgesic

medical device (EAD) in reducing or

mitigating acute and/or chronic

intractable pain conditions.

By Robert H. Odell, Jr., MD, PhD; Richard Sorgnard, PhD; and Hans Ulrich May, MD

ELECTROANALGESIC

NERVE BLOCK

www.podiatrym.com

JUNE/JULY 2014 | PODIATRY MANAGEMENT

PROFILES IN EXCELLENCE 2014

150

By Ellen R. Delisio Conditions such as peripheral neuropathy and other

similar neurogenic conditions are the most frustrating

for podiatrists and the most painful and discouraging for

patients. In the past, faced with patients who have had

pain, numbness, tingling in their feet for months or years,

practitioners knew their treatment options were limited

and often only minimally successful.

Now numerous podiatrists are seeing dramatic results

with the NEUROGENX Solution, which offers a conser-

vative standalone patented, FDA-Cleared Electronic Sig-

nal Treatment (EST) Technology. The treatment may be

differentially-augmented with a specific local anesthetic.

This minimally-invasive, targeted approach pairing EST

and a local has been coined in the literature as an Inte-

grated Nerve Block (INB) or Combined Electrochemical Treatment or Block (CET or CEB). The EST and CET have been used by physi-cians in a number of spe-cialties (such as pain man-agement) and now are being hailed by podiatrists as a life-changer for people who were resigned to living with pain and limited mobility. “I’m happy for the pa-tients; to give them hope to resume daily living is very rewarding,” said Dr. Jean Chen-Vitulli DPM, MS, of Middletown, NY, who treats patients and trains other podiatrists to use the

NEUROGENX device. Patients with neuropathic pain rep-

resent approximately 75 percent of her practice and she is

concentrating on building a base of home-bound patients.

“I’ve seen very positive results when this is used with

elderly patients,” Dr. Chen-Vitulli said. “One person went

from taking three Percocet tablets a day to sometimes just

one, sometimes none. I have about an 85-to-90-percent

success rate.” What sets NEUROGENX apart is the machine, accord-

ing to James Martellini, NEUROGENX Program Director.

“This exclusive medical device sweeps from higher fre-

quencies (40,000 Hertz) to lower frequencies (400 Hertz).

It produces a more sophisticated ‘Bio-Similar’ waveform

with a rapid-rise and a slow-decay comparable to what the

body produces in the form of action potentials along the

surface of the nerve membrane,” he said. “Sustained depo-

larization occurs at the membrane maintaining voltage-de-

pendent gateways open. What the cell needs, energy, is

driven in while what impedes, fluid and H ions, are driven

out. The result is increased cellular metabolism measured

by increased cAMP levels. The body is amazingly restor-

ative if enough of what impedes is removed and enough

of what it needs is added. The body is engaged and lever-

aged. A wide range of frequencies and a bio-similar wave-

form allow for more communication with all the various

nerve fibers and concurrently more uptake of energy.”

“This leads to rapid and restorative motor and senso-

ry results. Retesting with nerve conduction studies and

nerve fiber density testing, usually starting six months

post-discharge, objectively validates these results.”

Dr. Marilyn Butler-Murphy, DPM, of Manhasset, N.Y.,

has treated one person with the NEUROGENX system

since undergoing training in March, a man who has been

her patient for 20 years and dreaded walking because of

pain, heaviness in his feet and an unsteady gait. After just one treatment, he was able to walk more comfortably. “He loves the results,” said Dr. Butler-Murphy, after treating the man six times. “He’s walking better. He could not walk back-wards before without losing his balance and the numb-ness in his toes is gone. I have been in practice for 30 years, so it’s nice when something new comes along.” Other approaches she used over the years had limited success. “I was giv-ing patients different sup-plements for neuropathy;

vitamins, prescriptions, activities—and they didn’t really

help enough.” The treatment protocol usually begins with EST alone

and is augmented as needed early on for a time with a

specific and targeted low-dose local anesthetic. “The local

anesthetic addresses the pain early and helps increase

permeability at the nerve membrane which really accel-

erates the results,” according to Martellini, “but EST does

the heavy lifting and the treatment protocol usually ends

with EST alone. In combination EST and the local anesthetic creates a

symbiotic, synergistic effect. No numbness is experienced

from the local anesthetic paired with EST and EST drives

the local anesthetic to the more conductive tissue; it pro-

duces and delivers electronic biologically-effective signals.

EST can be used to help with neuropathic pain caused

from diabetes, viral infection and mechanical/chemical

insults among others, along with inflammatory conditions,

like plantar fasciitis, as well as vascular conditions. This

information from NEUROGENX includes published studies.

Circle #158

Neurogenx Gets High Marks for Treating Nerve Pain

NOT All Electrophysical Medical Devices Are Created Equal (It’s more than just a TENS unit)

TENS Inferential Nerve Stimulation

NEUROGENX 4000 Pro

Frequency Less than 1000 HZ 4000-4400HZ 40,000 HZ - 400 HZ

Wave Form Rudimentary Biphasic

Simple Sinusodial

SophisticatedBio-Similar

Since Neurogenx delivers electronic signals at higher, more therapeutic frequency rates than similar electro-physical equipment, it is patented and FDA-cleared as the only device of its kind. The higher frequency combined with a sophisticated electrical wave form that is similar to that of the human body, allows the therapeutic signal to penetrate deeper, affecting change at the cellular level and increasing cellular metabolism. Needed energy is driven in, while impediments such as fluid and hydrogen are driven out. This leads to rapid restorative motor and sensory results and a dramatic decrease in pain.